Frontiers in Immunology (Apr 2021)

Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?

  • Chiel van Geffen,
  • Astrid Deißler,
  • Astrid Deißler,
  • Markus Quante,
  • Harald Renz,
  • Harald Renz,
  • Dominik Hartl,
  • Dominik Hartl,
  • Saeed Kolahian,
  • Saeed Kolahian,
  • Saeed Kolahian

DOI
https://doi.org/10.3389/fimmu.2021.663203
Journal volume & issue
Vol. 12

Abstract

Read online

The immune system is receiving increasing attention for interstitial lung diseases, as knowledge on its role in fibrosis development and response to therapies is expanding. Uncontrolled immune responses and unbalanced injury-inflammation-repair processes drive the initiation and progression of idiopathic pulmonary fibrosis. The regulatory immune system plays important roles in controlling pathogenic immune responses, regulating inflammation and modulating the transition of inflammation to fibrosis. This review aims to summarize and critically discuss the current knowledge on the potential role of regulatory immune cells, including mesenchymal stromal/stem cells, regulatory T cells, regulatory B cells, macrophages, dendritic cells and myeloid-derived suppressor cells in idiopathic pulmonary fibrosis. Furthermore, we review the emerging role of regulatory immune cells in anti-fibrotic therapy and lung transplantation. A comprehensive understanding of immune regulation could pave the way towards new therapeutic or preventive approaches in idiopathic pulmonary fibrosis.

Keywords